Pear therapeutics logo
WebBusiness Insider Intelligence. Swiss drug maker Novartis' Sandoz ended its partnership with Pear Therapeutics, which started in 2024 and was aimed at helping Pear market its FDA … WebJun 22, 2024 · Pear Therapeutics, which has three FDA-authorized apps to treat psychiatric disorders, plans to go public in a $1.6 billion special purpose acquisition corporation, or …
Pear therapeutics logo
Did you know?
WebJun 23, 2024 · Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. Pear aims to redefine medicine by discovering, developing, and delivering clinically validated software-based ... WebJun 22, 2024 · The $1.6 billion valuation attached to its SPAC deal puts Pear at the head of its rivals in terms of funding raised. In May, fellow digital therapeutics company Akili …
WebJun 22, 2024 · Pear Therapeutics, which has three FDA-authorized apps to treat psychiatric disorders, plans to go public in a $1.6 billion special purpose acquisition corporation, or SPAC deal, the company... WebOct 16, 2024 · Editor's Note: This story has been updated with additional quotes from Pear Therapeutics. The poster child of digital therapeutics-pharma collaborations is soon to be no more, as Novartis division Sandoz announced that it is handing sole responsibility for the commercialization of the reSET and reSET-O prescription digital therapeutics back to …
WebMar 17, 2024 · Pear’s stock closed at 39 cents a share on Friday, down 34% from 59 cents at yesterday’s close. The Boston-based company had raised $250 million in venture funding from investors including ... Web1 day ago · Pear Therapeutics (NASDAQ: PEAR) stock is falling on Friday after the company’s recent bankruptcy filing continues to weigh on its shares. Pear Therapeutics …
WebApr 3, 2024 · Pear Therapeutics has an analyst consensus of Hold, with a price target consensus of $3.67, representing a 1,339.22% upside. In a report released on March 20, …
WebPear Therapeutics is registered under the ticker NASDAQ:PEAR . Stock Symbol NASDAQ:PEAR Valuation at IPO $1.6B Money Raised at IPO $400M IPO Date Dec 3, 2024 Stock chart by Investors Number of Lead Investors 6 Number of Investors 23 Pear Therapeutics is funded by 23 investors. easy job with high salary in canadaWebApr 14, 2024 · Among that is what has shares of Pear Therapeutics (NASDAQ: PEAR ), Petros Pharmaceuticals (NASDAQ: PTPI ), CXApp (NASDAQ: CXAI) stock moving today. You can find out all of this news at the... easy jobs with health insuranceWebMar 17, 2024 · Published: March 17, 2024 at 9:53 a.m. ET. By Dean Seal. Pear Therapeutics Inc. said Friday that it is exploring strategic alternatives, including a potential sale. The developer of prescription ... easy joint basalt wickesWebLooking forward to the analysis (but not punditry) about the arc of Pear Therapeutics. Not every company is going to make it, but many of the people at Pear… Paul Andrew Parker on LinkedIn: Pear Therapeutics Files for Chapter 11 and Will Seek to Sell Assets… easy joining of binding endsWebPear Therapeutics, Inc. is a commercial-stage healthcare company pioneering a new class of software-based medicines, sometimes referred to as Prescription Digital Therapeutics … easy joint grout calculatorWebCompany - Public ( PEAR) Industry: Biotech & Pharmaceuticals. Revenue: $1 to $5 million (USD) Competitors: Unknown. Pear Therapeutics is the leader in prescription digital therapeutics. We aim to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients ... easy johnny cash songs guitarWebJun 22, 2024 · Pear Therapeutics, Inc. (“Pear”) has built the first end-to-end platform for prescription digital therapeutics (PDTs), which are FDA-authorized, clinician-prescribed, and payor-reimbursed ... easy john prine songs for guitar